New study flags smaller-than-expected muscle impact from GLP-1 medications

1 min read
Source: The Washington Post
New study flags smaller-than-expected muscle impact from GLP-1 medications
Photo: The Washington Post
TL;DR

A new study suggests GLP-1 weight-loss drugs (such as Ozempic and Wegovy) may not cause as much muscle loss as previously feared, while reinforcing the importance of regular exercise to preserve muscle when taking these medications.

Share this article

Want the full story? Read the original reporting

Read on The Washington Post